A New Look at Some Old and Not So Old Drugs: A 2018 Update on Cocaine Research

CMEO Webcast

Live Webcast: Wednesday, February 21, 2018
1:00 PM – 2:30 PM ET

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Thursday, February 21, 2019

Faculty

Mark S. Gold, MD Mark S. Gold, MD (Moderator)
Chairman, Scientific Advisory Boards, RiverMend Health
Adjunct Professor of Psychiatry
Washington University School of Medicine
St. Louis, MO
17th University of Florida Distinguished Alumni Professor
Gainesville, FL

 

Leah-Perle Bloomenstein Leah-Perle Bloomenstein
Intelligence Research Specialist
Domestic Strategic Intelligence Unit
Drug Enforcement Administration (DEA)

 

Jean Lud Cadet, MD Jean Lud Cadet, MD
Senior Investigator (tenured)
Chief, Molecular Neuropsychiatry Research Branch
Chief, Molecular Neuropsychiatry Section
National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) Intramural Research Program
Baltimore, MD

 

Thomas R. Kosten, MD Thomas R. Kosten, MD
JH Waggoner Chair and Professor of Psychiatry, Neuroscience, Pharmacology, Immunology & Pathology
Director, Institute for Clinical and Translational Research
Baylor College of Medicine
Houston, TX

Statement of Need

Over the past 10 years, the drug landscape has shifted as the opioid crisis has impacted so many in the United States. While this has rightfully garnered much of the attention related to substances of abuse, a new report, 2017 National Drug Threat Assessment, released from the DEA has identified cocaine as an emerging threat resulting from rebounding use.

We invite you to join a live webstream of the DEA Museum Lecture Series featuring an esteemed panel of experts moderated by Mark Gold, MD as they provide their expertise and insights on the remerging threat of cocaine in America.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Increase awareness of current cocaine use and deaths compared to last cocaine epidemic.
  • Recognize the neurobiological underpinnings of cocaine use on the brain and the resulting damage that may occur.
  • Explore potential treatments for cocaine overdose and addiction.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Summarize current cocaine use and deaths compared to last cocaine epidemic.
  • Describe the neurobiological underpinnings of cocaine use on the brain and the resulting damage that may occur.
  • Identify potential treatments for cocaine overdose and addiction.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses and pharmacists.

Credit Information

CME Credit (Physicians):
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC and The Drug Enforcement Administration. CME Outfitters, LLC is accredited by the ACCME to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live actvity for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours

CPE Credit (Pharmacists):
ACPECME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number: 0376-9999-18-004-L01-P

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST26348 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Gold serves as Chairman on the Scientific Advisory Board for RiverMend Health.

Jan Perez (planning committee) has no disclosures to report.

Disclosures have been obtained from CME Outfitters staff: No disclosures to report.

Unlabeled Use Disclosure

Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.